Horvath, G.; Plesz, S.B.; Ducza, E.; Varga, D.; Szucs, E.; Benyhe, S.; Adlan, L.G.; Braunitzer, G.; Kekesi, G.
Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model. Int. J. Mol. Sci. 2025, 26, 6019.
https://doi.org/10.3390/ijms26136019
AMA Style
Horvath G, Plesz SB, Ducza E, Varga D, Szucs E, Benyhe S, Adlan LG, Braunitzer G, Kekesi G.
Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model. International Journal of Molecular Sciences. 2025; 26(13):6019.
https://doi.org/10.3390/ijms26136019
Chicago/Turabian Style
Horvath, Gyongyi, Szonja Bianka Plesz, Eszter Ducza, Dorottya Varga, Edina Szucs, Sándor Benyhe, Leatitia Gabriella Adlan, Gabor Braunitzer, and Gabriella Kekesi.
2025. "Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model" International Journal of Molecular Sciences 26, no. 13: 6019.
https://doi.org/10.3390/ijms26136019
APA Style
Horvath, G., Plesz, S. B., Ducza, E., Varga, D., Szucs, E., Benyhe, S., Adlan, L. G., Braunitzer, G., & Kekesi, G.
(2025). Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model. International Journal of Molecular Sciences, 26(13), 6019.
https://doi.org/10.3390/ijms26136019